Panacea Stars: Catalysing Success in Science

Panacea Stars: Catalysing Success in Science

Since our inception in Oxford in 2015, Panacea has helped build hundreds of science and health ventures. We back founders at the point where breakthrough science begins its journey toward company creation. Our model combines venture building, strategic support, and access to capital to help exceptional teams move earlier, faster, and with more clarity towards building category-defining businesses.

Exclusive Venture Building and Investment Support
We support teams and companies at all stages, from early ideas to ventures preparing for market entry or fundraising. We work across the full life sciences and healthcare spectrum, including therapeutics, diagnostics, medtech, digital health, and AI-enabled platforms, with particular interest in Bio-AI companies. The programme is built for ambitious scientists, clinicians, engineers, and entrepreneurs ready to turn high-potential innovation into enduring ventures.

Our equity-free, no-strings attached, Stride Venture Building Programme is designed to help founders make the transition from promising science to investable company. Stride brings scientific insight and commercial discipline into the same room. Participants sharpen product-clinic fit, refine commercial strategy, strengthen their narrative, and build the foundations of a company that can raise capital, attract talent, and execute with focus.

What founders gain

Founders receive hands-on support to validate the opportunity, define the market, sharpen their pitch, and build investor-grade materials. They gain practical insight into IP, regulatory affairs, product development, and commercial strategy, alongside direct access to experienced founders, operators, industry experts, and key opinion leaders. Through Panacea’s venture-building model and the Panacea Guild mentors and alumni network, participants gain advice, relationships, perspective, and the momentum needed to move from technical promise to investment readiness.

What sets Panacea apart
We work closely with founders to pressure-test the science, the strategy, and the market from the outset. That means helping teams reduce risk early, focus on what matters, and build with conviction. Through expert mentoring, targeted support, and access to a high-value network, participants leave with sharper plans, stronger materials, and a much clearer path to commercialisation and fundraising.

Capital pathway through Panacea Capital
The most promising ventures may also gain access to Panacea Capital. This creates a direct path from venture building to long-term investment support, with capital designed to back exceptional companies early and support them as they scale. For the strongest teams, Stride is not only a programme. It is an entry point into a wider platform for building and financing the next generation of Bio-AI and healthcare companies.

Join Our Panacea @ London Stride Spring/Summer 2026 Cohort

We are now inviting the next wave of outstanding innovators to join our equity-free Stride Venture Building Programme for the Spring/Summer 2026 cohort.

The deadline for applications is 22 May 2026. This is an opportunity for founders and future founders to build an investable venture, sharpen their commercial strategy, and accelerate the path from breakthrough innovation to real-world impact. Apply now here. 

For more information, please visit our website.